Share
a year ago
AstraZeneca to invest $2.5bn in China after scandal
a year ago
AstraZeneca to invest $2.5bn in drugs research and manfacturing in Beijing
Tags: AstraZeneca, manfacturing, Beijing, China, drugs research, scandal,
Enter your email to subscribe to news alerts
Subscribe
←Top Latest Headlines